Zeffix
Zeffix is a medicine authorised by Swissmedic under authorisation number 54869. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 24 March 1999 and the authorisation is valid without a time limit. ATC code J05AF05 places the medicine in the group Antivirals for systemic use.
| Authorisation number | 54869 |
|---|---|
| Name | Zeffix |
| Full name | Zeffix, Lösung zum Einnehmen |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J05AF05 |
| First authorisation | 24 March 1999 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zeffix, Lösung zum Einnehmen | A | 24 March 1999 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 10 | 240 | ml | J05AF05 | 08.03.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zeffix authorised in Switzerland?
Yes. Zeffix is authorised by Swissmedic under authorisation number 54869, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zeffix have?
Zeffix is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Zeffix?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.